Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by stocknyoudownon Jun 22, 2002 2:05am
181 Views
Post# 5230578

looks like partner might hold

looks like partner might hold a piece of the puzzle in regards to the troponin cardiac marker, i understand i'm late to this party but has anyone else ever heard of ischemia technologies? could be a marriage made in heaven!!! and i quote "ima has been proven a clinicaly useful tool to enable earlier diagnosis of patients with ami particulary when used in conjunction with troponin" early clinical results have suggested that ima will prove useful as a biochemical marker of ischemia. multicenter clinical studies are underway to investigate ima as an aid to diagnosis of cardiac ischemia. hold onto those shares!!!! stockn
Bullboard Posts